Abstract
Cefoxitin, a parenteral cephamycin β-lactam antibiotic, was evaluated for safety and efficacy in children with bacterial infections other than meningitis. Twentysix patients between 3 months and 7 years of age were treated with 80 to 160 mg/kg per day. The most common diagnoses were cellulitis (13 patients), pneumonia (5 patients), and bone and joint infection (4 patients). Nine patients were bacteremic. The most frequently recovered pathogens were Staphylococcus aureus (six patients), Haemophilus influenzae (four patients), and Streptococcus pneumoniae (three patients). All organisms were susceptible to cefoxitin. All 26 children were considered improved or cured. No severe adverse reactions were encountered. Phlebitis (4%), eosinophilia (12%), and elevated liver function tests (4%) were associated with therapy. Cefoxitin appears to be a safe, effective, and well-tolerated antibiotic when used in children with susceptible bacterial infections other than meningitis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Eickhoff T. C., Ehret J. M. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin. Antimicrob Agents Chemother. 1976 Jun;9(6):994–999. doi: 10.1128/aac.9.6.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gurwith M., Albritton W., Lank B., Harding G., Ronald A. Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria. Antimicrob Agents Chemother. 1978 Feb;13(2):255–260. doi: 10.1128/aac.13.2.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heseltine P. N., Busch D. F., Meyer R. D., Finegold S. M. Cefoxitin: clinical evaluation in thirty-eight patients. Antimicrob Agents Chemother. 1977 Mar;11(3):427–434. doi: 10.1128/aac.11.3.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCloskey R. V. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic. Antimicrob Agents Chemother. 1977 Nov;12(5):636–641. doi: 10.1128/aac.12.5.636. [DOI] [PMC free article] [PubMed] [Google Scholar]